Research programme: sodium channel antagonists - NeuroSearch/Pierre Fabre
Latest Information Update: 13 Jul 2006
At a glance
- Originator Pierre Fabre
- Class
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cerebral ischaemia; Epilepsy; Major depressive disorder; Pain
Most Recent Events
- 13 Jul 2006 Discontinued - Preclinical for Cerebral ischaemia in Denmark (unspecified route)
- 13 Jul 2006 Discontinued - Preclinical for Depression in Denmark (unspecified route)
- 13 Jul 2006 Discontinued - Preclinical for Epilepsy in Denmark (unspecified route)